ActiveDriver identifies N-terminal mutations in five cancer types as highly significant (n = 73, FDR p = 2.5e − 92 from ActiveDriver; Fig. 2b), confirming constitutive activation of CTNNB1 via disrupted phosphorylation as a prevalent driving mechanism of cancer. The gene discussed is CTNNB1; the disease is cancer.